BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 31659118)

  • 21. Synergistic Cytotoxic Effect of L-Asparaginase Combined with Decitabine as a Demethylating Agent in Pediatric T-ALL, with Specific Epigenetic Signature.
    Serravalle S; Bertuccio SN; Astolfi A; Melchionda F; Pession A
    Biomed Res Int; 2016; 2016():1985750. PubMed ID: 28003999
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Asparagine synthetase: Function, structure, and role in disease.
    Lomelino CL; Andring JT; McKenna R; Kilberg MS
    J Biol Chem; 2017 Dec; 292(49):19952-19958. PubMed ID: 29084849
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bisabosqual A: A novel asparagine synthetase inhibitor suppressing the proliferation and migration of human non-small cell lung cancer A549 cells.
    Pan Y; Suzuki T; Sakai K; Hirano Y; Ikeda H; Hattori A; Dohmae N; Nishio K; Kakeya H
    Eur J Pharmacol; 2023 Dec; 960():176156. PubMed ID: 38059445
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metabolic Alterations Caused by KRAS Mutations in Colorectal Cancer Contribute to Cell Adaptation to Glutamine Depletion by Upregulation of Asparagine Synthetase.
    Toda K; Kawada K; Iwamoto M; Inamoto S; Sasazuki T; Shirasawa S; Hasegawa S; Sakai Y
    Neoplasia; 2016 Nov; 18(11):654-665. PubMed ID: 27764698
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regulation of asparagine synthetase gene transcription by the basic region leucine zipper transcription factors ATF5 and CHOP.
    Al Sarraj J; Vinson C; Thiel G
    Biol Chem; 2005 Sep; 386(9):873-9. PubMed ID: 16164412
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differences in the molecular mechanisms involved in the transcriptional activation of the CHOP and asparagine synthetase genes in response to amino acid deprivation or activation of the unfolded protein response.
    Bruhat A; Averous J; Carraro V; Zhong C; Reimold AM; Kilberg MS; Fafournoux P
    J Biol Chem; 2002 Dec; 277(50):48107-14. PubMed ID: 12351626
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enhanced expression of asparagine synthetase under glucose-deprived conditions promotes esophageal squamous cell carcinoma development.
    Fang K; Chu Y; Zhao Z; Li Q; Li H; Chen T; Xu M
    Int J Med Sci; 2020; 17(4):510-516. PubMed ID: 32174781
    [No Abstract]   [Full Text] [Related]  

  • 28. Asparagine synthetase as a causal, predictive biomarker for L-asparaginase activity in ovarian cancer cells.
    Lorenzi PL; Reinhold WC; Rudelius M; Gunsior M; Shankavaram U; Bussey KJ; Scherf U; Eichler GS; Martin SE; Chin K; Gray JW; Kohn EC; Horak ID; Von Hoff DD; Raffeld M; Goldsmith PK; Caplen NJ; Weinstein JN
    Mol Cancer Ther; 2006 Nov; 5(11):2613-23. PubMed ID: 17088436
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low expression of asparagine synthetase in lymphoid blasts precludes its role in sensitivity to L-asparaginase.
    Hermanova I; Zaliova M; Trka J; Starkova J
    Exp Hematol; 2012 Aug; 40(8):657-65. PubMed ID: 22542578
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Upregulation of asparagine synthetase fails to avert cell cycle arrest induced by L-asparaginase in TEL/AML1-positive leukaemic cells.
    Krejci O; Starkova J; Otova B; Madzo J; Kalinova M; Hrusak O; Trka J
    Leukemia; 2004 Mar; 18(3):434-41. PubMed ID: 14724653
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Asparagine depletion potentiates the cytotoxic effect of chemotherapy against brain tumors.
    Panosyan EH; Wang Y; Xia P; Lee WN; Pak Y; Laks DR; Lin HJ; Moore TB; Cloughesy TF; Kornblum HI; Lasky JL
    Mol Cancer Res; 2014 May; 12(5):694-702. PubMed ID: 24505127
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cell cycle-dependent recruitment of polycomb proteins to the ASNS promoter counteracts C/ebp-mediated transcriptional activation in Bombyx mori.
    Li Z; Cheng D; Mon H; Zhu L; Xu J; Tatsuke T; Lee JM; Xia Q; Kusakabe T
    PLoS One; 2013; 8(1):e52320. PubMed ID: 23382816
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of GCN2 sensitizes ASNS-low cancer cells to asparaginase by disrupting the amino acid response.
    Nakamura A; Nambu T; Ebara S; Hasegawa Y; Toyoshima K; Tsuchiya Y; Tomita D; Fujimoto J; Kurasawa O; Takahara C; Ando A; Nishigaki R; Satomi Y; Hata A; Hara T
    Proc Natl Acad Sci U S A; 2018 Aug; 115(33):E7776-E7785. PubMed ID: 30061420
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dynamic changes in genomic histone association and modification during activation of the ASNS and ATF3 genes by amino acid limitation.
    Balasubramanian MN; Shan J; Kilberg MS
    Biochem J; 2013 Jan; 449(1):219-29. PubMed ID: 22978410
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pancreatic tumor sensitivity to plasma L-asparagine starvation.
    Dufour E; Gay F; Aguera K; Scoazec JY; Horand F; Lorenzi PL; Godfrin Y
    Pancreas; 2012 Aug; 41(6):940-8. PubMed ID: 22513289
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Coordination of asparagine uptake and asparagine synthetase expression modulates CD8+ T cell activation.
    Hope HC; Brownlie RJ; Fife CM; Steele L; Lorger M; Salmond RJ
    JCI Insight; 2021 May; 6(9):. PubMed ID: 33822775
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enhanced expression of asparagine synthetase under glucose-deprived conditions protects pancreatic cancer cells from apoptosis induced by glucose deprivation and cisplatin.
    Cui H; Darmanin S; Natsuisaka M; Kondo T; Asaka M; Shindoh M; Higashino F; Hamuro J; Okada F; Kobayashi M; Nakagawa K; Koide H; Kobayashi M
    Cancer Res; 2007 Apr; 67(7):3345-55. PubMed ID: 17409444
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ATF4 is a mediator of the nutrient-sensing response pathway that activates the human asparagine synthetase gene.
    Siu F; Bain PJ; LeBlanc-Chaffin R; Chen H; Kilberg MS
    J Biol Chem; 2002 Jul; 277(27):24120-7. PubMed ID: 11960987
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Asparagine synthetase chemotherapy.
    Richards NG; Kilberg MS
    Annu Rev Biochem; 2006; 75():629-54. PubMed ID: 16756505
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Asparagine synthetase is a predictive biomarker of L-asparaginase activity in ovarian cancer cell lines.
    Lorenzi PL; Llamas J; Gunsior M; Ozbun L; Reinhold WC; Varma S; Ji H; Kim H; Hutchinson AA; Kohn EC; Goldsmith PK; Birrer MJ; Weinstein JN
    Mol Cancer Ther; 2008 Oct; 7(10):3123-8. PubMed ID: 18852115
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.